Sustainable leadership Position ACC as a pioneer in sustainable recombinant LAL technology with PyroSmart NextGen to appeal to pharma and biotech buyers seeking animal-free, compliant endotoxin testing solutions across pharmaceutical, medical-device, and diagnostic segments.

Global reach Leverage ACC’s multinational footprint and ISO/FDA/DEA/CLIA-certified labs to pursue opportunities in Europe and North America, emphasizing quick method transfer, custom testing, and regulatory-compliant endotoxin and (1→3)-ß-D-glucan analysis.

Integrated services Cross-sell CTS endotoxin testing, LER studies, depyrogenation control design, and glucan analysis through the CLIA-certified lab to provide end-to-end quality control and product release solutions for biotech, pharma, and compounding pharmacies.

Brand trust Highlight ACC’s historic leadership in LAL reagent development and its award-winning innovation to build credibility with procurement and QA teams seeking established vendors with robust regulatory alignment.

Growth channels Target pharmaceutical manufacturers, contract manufacturers, and medical device companies expanding endotoxin and glucan testing needs, while leveraging partnerships, distributors in Europe, and the customer successes from PyroSmart NextGen to accelerate deal creation.